Desktop Site |
19 Apr 24 | 11:59 | Open
Equity SME Eq Drv Currency Commodity Corporates
Get Quote
Notices |
S&P BSE SENSEX 72,218.56 -270.43 -0.37 %
Corporate Announcement
  • Security Code524715
    CompanySun Pharmaceutical Industries Ltd
    Exchange Received Time18/05/2020 18:49:14
    Exchange Disseminated Time18/05/2020 18:49:23
    Time Taken00:00:09
     
     
     Board Meeting Intimation for Consideration And Approval Of Audited Standalone And Consolidated Financial Results Of The Company For The Fourth Quarter And Year Ended On March 31, 2020 And To Consider Recommendation Of Final Dividend For The Year Ended March 31, 2020 | 5/18/2020 6:49:17 PM 
     SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2020 ,inter alia, to consider and approve (i) To consider and approve Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2020.

    (ii) To consider recommendation of final dividend for the year ended March 31, 2020 subject to the approval of the shareholders at the ensuing Annual General Meeting.    		 
    AttachmentDownload PDF
     
    << Back  
     
Recently Viewed
Copyright@ 2015. All Rights Reserved. BSE Ltd.
(20H) 19 Apr 24|11:59 (IST)